Results 161 to 170 of about 42,587 (212)

Anaplastic Lymphoma Kinase Rearrangement-Positive Pulmonary Adenocarcinoma With Scattered Bilateral Breast Metastases: A Case Report. [PDF]

Cureus
Matsuzaki S, Inoshima I, Hirasawa Y, Horii Y, Nobusawa S.   +4 more
europepmc   +1 more source

Radiomic features and tumor immune microenvironment associated with anaplastic lymphoma kinase-rearranged lung adenocarcinoma and their prognostic value. [PDF]

Front Genet
Han Y, Feng W, Li H, Wang H, Ye Z.
europepmc   +1 more source

A rare case of circulating anaplastic lymphoma kinase-negative anaplastic large cell lymphoma. [PDF]

Hematol Transfus Cell Ther
Chiriac R, Baseggio L.
europepmc   +1 more source

A humanized anaplastic lymphoma kinase (ALK)-directed antibody-drug conjugate with pyrrolobenzodiazepine payload demonstrates efficacy in ALK-expressing cancers. [PDF]

Nat Commun
Guerra AD, Matkar S, Acholla C, Casey C, Li G, Mazzeschi M, Patel K, Krytska K, Chen C, Balyasny S, Kalna J, Kamitsuka P, Gerelus M, Polkosnik G, Groff D, Mukherje A, Adams C, Witek G, Hamilton AK, Martinez D, Pogoriler J, Spear TT, Li Y, Jung P, Alvarado D, Lauriola M, Maris JM, Wolpaw AJ, Bosse KR, Dimitrov D, Mir M, Jelev DV, Mossé YP.   +32 more
europepmc   +1 more source

Pediatric Cutaneous Anaplastic Lymphoma Kinase-Positive Histiocytosis with <i>DCTN1::ALK</i> Fusion: A Case Report and Literature Search. [PDF]

Diagnostics (Basel)
Korpás KL, Mokánszki A, Beke L, Méhes G, Chang Chien YC.   +4 more
europepmc   +1 more source

Real-world first-line outcomes of alectinib and brigatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: a nationwide South Korean cohort study using the health insurance review and assessment data. [PDF]

Transl Lung Cancer Res
Kim HJ, Lee EA, Park JH, Lee HW.
europepmc   +1 more source

Targeting a cure in anaplastic lymphoma kinase-positive non-small cell lung cancer. [PDF]

Transl Lung Cancer Res
D'Amours MF, Ho C.
europepmc   +1 more source

Intravascular proliferating anaplastic lymphoma kinase-positive anaplastic large-cell lymphoma

World Journal of Hematology, 2015
openaire   +1 more source

Anaplastic Lymphoma Kinase (ALK) Fusion as a Resistance Mechanism to Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors With Complete Response After Osimertinib and Alectinib: A Case Report and Literature Review. [PDF]

Cureus
Cheung BMF, El Helali A, Leung DKC.
europepmc   +1 more source